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Abstract
Background: Bacterial vaginosis (BV), which is highly prevalent in the African population, is one of the most
common vaginal syndromes affecting women in their reproductive age placing them at increased risk for sexually
transmitted diseases including infection by human immunodeficiency virus-1. The vaginal microbiota of a healthy
woman is often dominated by the species belonging to the genus Lactobacillus namely L. crispatus, L. gasseri, L.
jensenii and L. iners, which have been extensively studied in European populations, albeit less so in South African
women. In this study, we have therefore identified the vaginal Lactobacillus species in a group of 40 African women
from Soweto, a township on the outskirts of Johannesburg, South Africa.
Methods: Identification was done by cultivating the lactobacilli on Rogosa agar, de Man-Rogosa-Sharpe (MRS) and
Blood agar plates with 5% horse blood followed by sequencing of the 16S ribosomal DNA. BV was diagnosed on
the basis of Nugent scores. Since some of the previous studies have shown that the lack of vaginal hydrogen
peroxide (H2O2) producing lactobacilli is associated with bacterial vaginosis, the Lactobacillus isolates were also
characterised for their production of H2O2.
Results: Cultivable Lactobacillus species were identified in 19 out of 21 women without BV, in three out of five women
with intermediate microbiota and in eight out of 14 women with BV. We observed that L. crispatus, L. iners, L. jensenii,
L. gasseri and L. vaginalis were the predominant species. The presence of L. crispatus was associated with normal
vaginal microbiota (P = 0.024). High level of H2O2 producing lactobacilli were more often isolated from women with
normal microbiota than from the women with BV, although not to a statistically significant degree (P = 0.064).
Conclusion: The vaginal Lactobacillus species isolated from the cohort of South African women are similar to those
identified in European populations. In accordance with the other published studies, L. crispatus is related to a normal
vaginal microbiota. Hydrogen peroxide production was not significantly associated to the BV status which could be
attributed to the limited number of samples or to other antimicrobial factors that might be involved.
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Background
The vaginal microbiota of a healthy woman is often domi-
nated by lactobacilli. The most commonly identified Lacto-
bacillus species include L. crispatus, L. gasseri, L. jensenii
and L. iners [1-3]. Lactobacilli are thought to play an im-
portant role in protecting the host from urogenital infec-
tion by lowering the environmental pH through lactic acid
production, by producing various bacteriostatic and bac-
tericidal substances such as hydrogen peroxide (H2O2) and
through competitive exclusion. Decrease in the number of
lactobacilli and overgrowth of diverse anaerobes is asso-
ciated with an increased incidence of bacterial vaginosis
(BV) [4,5], which is one of the most common vaginal syn-
dromes among women in their reproductive age [6-8]. BV
is associated with an increased susceptibility to sexually
transmitted diseases including infection by human im-
munodeficiency virus-1 (HIV-1) [9-11] where the elevated
vaginal pH associated with BV may allow the survival of
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HIV. Moreover, BV associated microbiota has been shown
to enhance HIV-1 transcription and replication [12].
It has previously been shown that exogenously applied
lactobacilli can persist on the mucosal surface of the va-
gina, displace BV and restore a normal vaginal microbiota
[13,14]. Given the high prevalence of BV in women in
many sub-Saharan African countries with HIV epidemics
(20%-60%), colonisation by exogenous lactobacilli may
help to reduce the risk of HIV-1 transmission [9]. Further-
more, delivery of a microbicide by lactobacilli colonising
the vagina has previously been suggested as a strategy for
prevention of HIV transmission, particularly in developing
countries [15].
Hence, a better understanding of the species compo-
sition and ecology of bacterial ecosystems may help to
develop better prophylaxis against BV and HIV. If the
Lactobacillus species isolated from African women are
similar to those in America and Europe, where probiotic
studies have been performed, similar strategies utilising
probiotic and engineered lactobacilli could be applied in
Africa. Some studies reported differences in the com-
position of vaginal microbiota among different ethnic
groups in North America, where a higher incidence of
vaginal communities not dominated by lactobacilli was
observed in black women [16,17]. However, the few
studies performed in Africa to date suggest that the va-
ginal Lactobacillus species predominant among black
women are similar to those dominating in American and
European studies [18,19].
In preparation to study the colonisation efficiency of
exogenously applied vaginal lactobacilli and to treat BV
in South African women, we have therefore identified
the cultivable vaginal Lactobacillus species in women
with or without BV in Soweto.
Methods
Sample collection
Forty premenopausal and HIV uninfected black women
aged 18–44 years with or without BV were recruited for
the study. Study participants were randomly selected
among women who visited the Perinatal HIV Research
Unit (PHRU) in Chris Hani Baragwanath Hospital, So-
weto and received voluntary HIV counseling and testing.
Inclusion criteria were their willingness to provide the
informed consent, passing the assessment of under-
standing, BHCG negative status (non-pregnant) and
belonging to a low risk group for HIV acquisition. The
women were non-menstruating and not taking antibio-
tics at the time of sample collection. Vaginal swabs were
collected in Amies agar gel medium with charcoal
(Copan Venturi TranssystemW Copan Diagnostics, Italy).
Simultaneously, a second similar swab was used to pre-
pare a smear on a glass slide for BV scoring. The ethical
approval for collection of swab samples was granted by
Human Research Ethics Committee (Medical), University
of the Witwatersrand, Johannesburg (Ethical permit num-
ber M011138). A regional ethical permit was also granted
by Regionala Etikprövningdnämnden, Stockholm, for ana-
lysing these samples (Diarienummer: 2012/1362-31/1).
Cultivation of lactobacilli
The swabs were transported at room temperature to the
laboratory in Sweden within a maximum of two days. The
swabs were directly streaked onto Rogosa agar (BD
Difco™ Rogosa SL agar, Becton, Dickinson and Company,
Spark, MD), Columbia agar (BD Difco™ Columbia Blood
Agar Base) with 5% horse blood and de Man-Rogosa-
Sharpe (MRS) agar (BD Difco™ Lactobacilli MRS broth)
within 24 hours of arrival. The swabs were then vortexed
in 1ml sterile PBS (pH 7.4) to prepare bacterial suspen-
sions. The bacterial suspensions were diluted tenfold se-
rially (three dilutions per suspension) and each dilution
(100 μl) was plated onto the three different agar plates as
described above [20]. Plates were incubated for 48 hours
at 37°C in an incubator in anaerobic condition using BD
GasPack™ EZ gaz generating systems (Becton, Dickinson
and Company, Sparks, MD). Colonies with different
morphology yielding variable rods were re-streaked. Re-
spective colonies from re-streaked plates were Gram
stained and the colonies with Gram positive rods were
used to inoculate the MRS broth medium. Small transpa-
rent colonies from blood agar plates yielding Gram positive
bacilli not growing in MRS broth were collected directly
from the plates and used for genomic DNA isolation. Gly-
cerol stocks (15%) were prepared and stored at −80°C. Eight
to 12 different colonies were picked per sample.
Identification of lactobacilli
Genomic DNA was extracted from lactobacilli using
Qiagen’s DNAeasy Blood & Tissue extraction kit (Qiagen
GmbH, Hilden, Germany). The isolates were identified to
the species level by sequencing the 16S ribosomal RNA
(rRNA) gene as described previously [21]. Briefly, the
complete 16S rRNA gene (1.5 kb) was amplified by PCR
using the primers P0 (50-GAGAGTTTGATCCTGGCT
CAG-30) and P6 (50-CTACGGCTACCTTGTTACGA-30)
and sequenced. The obtained sequences were then sub-
jected to nucleotide-nucleotide BLAST using BLASTN
(http://www.ncbi.nlm.nih.gov/) and subsequently compared
to the 16SrRNA sequences of typed strains to validate the
results. The identification of Lactobacillus species was con-
sidered confirmed if the sequences showed 99-100% hom-
ology with the typed strain. The following typed strains and
16S rRNA gene sequence (Genbank accession number)
were used for the comparisons: L. mucosae strain CCUG
43179 (AF126738), L. paracasei strain ATCC 25302
(HQ423165), L. ruminis strain ATCC 27782 (CP003032)
and NBRC 102161 (AB326354), L. crispatus strain ATCC
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33820 (AF257097) & DSM 20584T (FR683088), L. coleoho-
minis DSM 14060 (AM113776), L. vaginalis strain ATCC
49540 (AF243177) and KC19 (AF243154), L. iners strain
DSM 13335 (NR_036982) and CCUG 28746T (Y16329),
L. gasseri ATCC 33323 (AF519171) and L. jensenii strain
ATCC 25258 (AF243176).
Determination of BV
Vaginal smears were Gram stained and graded on a 10
point scale based on the presence of lactobacilli and
other anaerobes as described by Nugent [22] for normal
microbiota (score 0–3), intermediate microbiota (score
4–6) and BV (score 7–10). In brief, a score of zero to
four is given individually for the presence of lactobaci-
lli and for Gardnerella/Bacteroides morphotypes and a
score of zero to two for curved Gram variable rods. The
sum of all scores is a representative of the BV score. The
presence of epithelial cells covered with bacteria (clue
cells), a critical component of the Amsel’s clinical criteria
for BV, was also noted [23].
Hydrogen peroxide (H2O2) production test
Lactobacillus isolates were streaked onto a 20 ml MRS
agar plate containing 0.25 mg/ml 3,3’, 5,5’-tetramethyl-
benzidine (TMB) (Sigma-Aldrich, St-Louis, MO) and
0.01 mg/ml of horseradish peroxidase (HRP) (Sigma-
Aldrich). Plates were incubated in anaerobic condition
using the BD Gas Pack™ anaerobic container system for
72 hours and were exposed to air for 30 minutes before
scoring them for blue coloration. HRP generates O2
from any H2O2 produced by the lactobacilli which in
turn oxidises the TMB substrate to form a blue pigment.
On the basis of the blue coloration, isolates were scored
for H2O2 production as 0 for no blue coloration, 1 for
light blue, 2 for moderate and 3 for dark blue coloration.
Since it was difficult to culture L. iners on MRS agar
medium, L. iners isolates were not included in the H2O2
production test.
Statistical analysis
Fisher’s exact test was performed to test the relation bet-
ween BV status (normal microbiota vs. BV) and the pre-
sence of any lactobacilli, specific Lactobacillus species and
high/low H2O2-producing lactobacilli. Two-tailed P values
less than 0.05 were considered statistically significant. All
the comparisons were performed with GraphPad Prism 4
software (GraphPad Software, Inc., La Jolla, Ca).
Results
BV status and Lactobacillus colonisation
Nugent scoring of the Gram stained vaginal smears
revealed that 21 women had a normal vaginal micro-
biota, five had an intermediate microbiota and 14 had
BV. The presence of clue cells was observed in all the
women with BV but not in women with normal or inter-
mediate microbiota (Table 1). Lactobacillus colonisation
was observed in women both with and without BV,
where cultivable Lactobacillus species were identified in
19 out of 21 women with normal microbiota, in three
out of five women with intermediate microbiota and in
eight out of 14 women with BV.
A total of 196 isolates were cultured from 40 swabs and
30 women (75%) were identified with cultivable Lactoba-
cillus species. L. crispatus, L. iners and L. gasseri were
identified in 10 (33%), 8 (27%) and 7 (23%) women re-
spectively, whereas L. vaginalis and L. jensenii colonised
five (17%) women each. These were the most commonly
identified Lactobacillus species. Other Lactobacillus spe-
cies identified were L. ruminis, L. mucosae, L. paracasei
and L. coleohominis (Figure 1). Among the 30 women har-
bouring lactobacilli, nine were colonised by more than
one Lactobacillus species (Table 2). L. crispatus was only
isolated from women with normal microbiota whereas the
other predominant Lactobacillus species (L. jensenii,
L. gasseri, L. vaginalis and L. iners) were isolated from
women both with and without BV (Figure 2). The two
women who were colonised by L. ruminis only and the
one woman who was colonized by a mix of L. ruminis,
L. mucosae and L. paracasei were identified with BV and
intermediate microbiota, respectively. Colonisation by any
lactobacilli and in particular L. crispatus was significantly
associated with a normal vaginal microbiota (Fisher test,
normal vs. BV microbiota, P = 0.0386 and P = 0.024 res-
pectively) but not the colonisation by other Lactobacillus
species.
Hydrogen peroxide (H2O2) production and BV status
All the isolates but L. iners were tested and scored for
H2O2 production on a scale of zero to three on the basis
of blue coloration. L. iners was not evaluated for H2O2
production since they do not grow on MRS agar plates.
Production of H2O2 was observed in the majority of the
L. crispatus (90%), L. jensenii (86%) and L. vaginalis
(80%) isolates and in a lower proportion of the L. gasseri
isolates (30%). L. ruminis, L. coleohominis, L. paracasei
were non-producers. Among the most commonly iso-
lated species, the proportion of isolates producing high
levels of H2O2 (score 2 and 3) was significantly higher
(Fisher test, P<0.001) for L. jensenii (52 %), L. crispatus
(33 %) and L. vaginalis (79%) than L. gasseri (0%).
The isolation of strong H2O2 producers (either L. jensenii,
L. crispatus or L. vaginalis with a score of 2 or 3) was in
general more frequent in women with a normal microbiota
than in the women with an intermediate microbiota or BV.
However H2O2 production as an individual factor did not
contribute significantly to the normal vaginal microbiota
(Fisher test, normal Vs. BV microbiota, P = 0.064)
(Figure 3).
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Discussion
With an increasing number of HIV-1 infected individuals
and women being at a higher risk of acquiring HIV infec-
tion, it is of great importance to improve women’s vaginal
health especially in the high risk population for sexually
transmitted diseases. It is estimated that nearly one-third
of all new HIV cases in South African population might be
prevented if all cases of BV could be cured [9]. With an
aim to restore the vaginal health through the adminis-
tration of exogenous Lactobacillus among South African
women, it was important to identify the Lactobacillus spe-
cies that colonise women in this region. Our finding indi-
cates that the Lactobacillus species (L. crispatus, L. iners,
L. gasseri, L. vaginalis and L. jensenii) that dominate the
vaginal microbiota in our cohort are similar to those pre-
dominating in European and American women [1,2,24].
Our results are in accordance with studies conducted by
Akunam et al. [19] in Nigeria and more recently, Damelin
et al. in South Africa [18], where the same predominant
vaginal Lactobacillus species were isolated.
As previously reported, the presence of Lactobacillus
species was a major determinant of a normal vaginal
microbiota [25,26]. More particularly, the isolation of
L. crispatus was strongly associated with the normal va-
ginal microbiota of women in the study as none of the
women colonised by L. crispatus had BV or an inter-
mediate microbiota. A number of previous studies have
also shown an association between absence of BV and
the presence of L. crispatus [1,2,24]. Furthermore, longi-
tudinal analysis of the microbiota has shown that the
presence of L. crispatus promotes stability of the vaginal
microbiota [26]. The ability of L. crispatus to produce
H2O2 has been suggested as an important factor in
maintaining the normal vaginal mirobiota as most of the
Table 1 Study participants characteristics
Normal Intermediate BV Women
Total
N=21 N=5 N=14 40








Median (and range) of
Nugent scores
1 (0–2) 5 (4–6) 8 (8–10)
Number of samples with
clue cells












19 3 8 30
Presence of L. crispatus
on culture

















Figure 1 Distribution of colonising Lactobacillus species in South African women. The number and percentage of women colonised by the
Lactobacillus species is indicated in parenthesis.
Table 2 Colonising Lactobacillus species in thirty women





L. crispatus 4 4
L. iners 7 4 1 2
L. gasseri 4 2 1 1
L. jensenii 2 1 1
L. vaginalis 2 1 1
L. ruminis 2 2
L. crispatus, L. jensenii 2 2
L. crispatus, L. gasseri 1 1
L. crispatus, L. vaginalis 1 1
L. crispatus, L. coleohominis 1 1
L. iners, L. vaginalis 1 1
L. crispatus, L. vaginalis, L. gasseri 1 1
L. mucosae, L. paracasei, L. ruminis 1 1
L. gasseri, L. jensenii 1 1
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L. crispatus strains were found to be strong H2O2 pro-
ducers [5]. On the contrary, L. iners, L. gasseri and
L. jensenii were isolated from women with normal
microbiota and BV. The presence of these Lactobacillus
species in women with BV could be due to their poorer
colonisation resistance, thereby allowing overgrowth of
other bacteria or due to their better resistance for the
environmental conditions associated with BV. Longitu-
dinal studies in pregnant women have shown that the
women harboring these Lactobacillus species, particu-
larly L. gasseri and L. iners, are more susceptible to BV
compared to the women colonised by L. crispatus [26].
It has also been suggested that L. iners may become a
dominant part of the vaginal microbiota when the
microbiota is in a transitional stage between abnormal
and normal [27].
The vast majority of clinical studies have established
an inverse association between BV and the occurrence
of vaginal H2O2-producing Lactobacillus species. In a 2-
year follow-up study, Hawes et al. documented that the
acquisition of bacterial vaginosis was strongly associated
with a lack or loss of hydrogen peroxide producing
lactobacilli [5]. Although the results of the numerous
clinical studies suggest that BV is caused by the lack of
vaginal H2O2-producing Lactobacillus species; the estab-
lished correlation may not necessarily indicate causality.
Lactobacilli that produce H2O2 have been shown in vitro
to inhibit the growth of various microorganisms, including
Gardnerella vaginalis, anaerobes, Neisseria gonorrhoeae as
well as the survival of HIV [28-31], but the relative contri-
bution of the H2O2 produced by the Lactobacillus species
to the overall antimicrobial effect is still a matter of de-
bate. Under the hypoxic conditions that generally prevail
in the vagina, H2O2 production by vaginal lactobacilli is
undetectable (detection threshold 10 nM). Additionally,
studies have shown that the cervicovaginal fluid and
semen have a significant H2O2-blocking activity and that
physiological concentrations of H2O2 below 100 μM did
not kill any of the tested BV-associated bacteria [32].
In this study, we found that the majority of L. crispatus,
L. jensenii and L. vaginalis isolates from South African
women were producing H2O2, corroborating previous
results [33,34]. Similar to the other reports, we have also
observed that a high proportion of L. crispatus, L. jensenii
and L. vaginalis isolates were strong H2O2 producers
while all the L. gasseri isolates were low producers
[24,30,33,35]. The presence of these strong H2O2 produ-
cers was higher in women with a normal microbiota al-
though not to a significant level. The absence of
significant inverse association between BV and the occur-
rence of vaginal H2O2-producing Lactobacillus species in
the present study could be due to different factors. Our
sample size was rather small and a single sampling occa-
sion may not properly reflect the status of the vaginal
microbiota of a woman as changes in the microflora du-
ring the menstrual cycle has been documented previously.
Several studies have indicated that Lactobacillus growth
increases throughout the menstrual cycle, but decreases
during the menses [36,37]. Furthermore, we did not re-
cord any behavioral factors that might have affected the
vaginal microbiota status during the study. Therefore, our
results need to be confirmed in a larger cohort preferably
using a longitudinal study design, combined with data on
subjects' behaviors.
The production of H2O2 by L. iners isolates was not
evaluated as these strains grow poorly on MRS contai-
ning TMB substrate. Most L. iners strains have been
found to be non-H2O2 producers which might correlate
with our finding that these species was isolated in both
BV positive and negative women [33]. The production of
H2O2 in this species should be assessed on medium
adapted for the growth of L. iners. Furthermore, the pro-
portion of H2O2 producing lactobacilli (and not only
their presence) might also be important and the relative
amount of lactobacilli should be determined by molecu-
lar methods. Finally, although the production of H2O2
by lactobacilli maybe an important factor for mainte-

























Figure 2 Association between colonising lactobacilli and BV
status defined by Nugent Score. * Significantly different





















Figure 3 Relation between hydrogen peroxide production by
lactobacilli and the Nugent score.
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competition for adherence and production of other anti-
microbial substances may also contribute to vaginal health
and might act in synergy with H2O2. Comparative ge-
nomic studies of the lactobacilli isolated from the vagina
of women with normal microbiota and BV might give a
clue of the factors involved in colonisation resistance.
Conclusions
The vaginal Lactobacillus species identified in black
South African women from Soweto are similar to those
identified in women from European populations. Colo-
nising Lactobacillus species, in particular L. crispatus,
contribute to a normal vaginal microbiota. High H2O2
producers were more frequently isolated from women
without BV, although not to a statistically significant
degree which might be due to the small sample size. The
similarity in the species composition between European
and African women suggest that, similar to the studies
conducted in North European populations [12,21], ad-
ministration of exogenously applied lactobacilli (pro-
biotic or designer probiotics) in South African women
could potentially be used for treatment of BV and thus
reduce the occurrence of infection by sexually transmit-
ted pathogens, including HIV-1.
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